| Oct 27 |
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
|
| Oct 26 |
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
|
| Oct 23 |
Bausch Health (BHC) Reports Next Week: What to Expect
|
| Oct 22 |
Bausch + Lomb Q3 Report Likely to Focus on Potential Sale, Dry Eye Disease Drugs, RBC Says
|
| Oct 21 |
Banks, Private Credit Vie for $5 Billion Bausch + Lomb Debt
|
| Oct 19 |
Bausch Health call volume above normal and directionally bullish
|
| Oct 17 |
Bausch rejects latest bondholder debt proposals - WSJ
|
| Oct 15 |
MT Newswires Canada Stocks To Watch: Bausch + Lomb; Descartes; International Petroleum Corp.; Osisko Development
|
| Oct 14 |
Why Bausch + Lomb Stock Soared by Over 7% on Monday
|
| Oct 14 |
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lenses
|
